Comprehensive Psychiatry
Volume 45, Issue 1 , Pages 10-15 , January 2004

Insight in obsessive compulsive disorder and body dysmorphic disorder

  • Jane L Eisen

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Jane L. Eisen, M.D., Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906, USA
    • Brown Medical School, Providence, RI, USA
  • ,
  • Katharine A Phillips

      Affiliations

    • Brown Medical School, Providence, RI, USA
  • ,
  • Meredith E Coles

      Affiliations

    • Department of Psychology, Binghamton University, Binghamton, NY, USA
  • ,
  • Steven A Rasmussen

      Affiliations

    • Brown Medical School, Providence, RI, USA

References 

  1. Brady KT, Austin L, Lydiard RB. Body dysmorphic disorder (the relationship to obsessive-compulsive disorder). J Nerv Ment Dis. 1990;178:538–540
  2. Tanquary J, Lynch M, Masand P. Obsessive-compulsive disorder in relations to body dysmorphic disorder. Am J Psychiatry. 1992;149:1283–1284
  3. Hollander E. Introduction. In:  Hollander E editors. Obsessive-Compulsive Related Disorders. Washington, DC: American Psychiatric Press; 1993;p. 95
  4. Cohen LJ, Stein DJ, Simeon D, Hollander E. Obsessive-compulsive spectrum disorders. In:  Hollander E,  Stein DJ editor. Obsessive-Compulsive Disorders. New York, NY: Marcel Dekker; 1997;p. 47–74
  5. Phillips KA. The obsessive compulsive spectrums. Psychiatr Clin North Am. 2002;25:791–809
  6. Phillips KA. Body dysmorphic disorder (the distress of imagined ugliness). Am J Psychiatry. 1991;148:1138–1149
  7. Saxena S, Winograd A, Dunkin JJ, Maidment K, Rosen R, Vapnik T, et al.  A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder. J Clin Psychiatry. 2002;62:67–72
  8. Philllips KA, Gunderson CG, Mallya G, McElroy SL, Carter W. A comparison study of body dysmorphic disorder and obsessive-compulsive disorder. J Clin Psychiatry. 1998;59:568–575
  9. McKay D, Neziroglu F, Yaryura-Tobias JA. Comparison of clinical characteristics in obsessive-compulsive disorder and body dysmorphic disorder. J Anxiety Disord. 1997;11:447–454
  10. Simeon D, Hollander E, Stein MB, Cohen L, Aronowit B. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. Am J Psychiatry. 1995;152:1207–1209
  11. Gunstad J, Phillips KA. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry. 2003;44:270–276
  12. Phillips KA. Pharmacologic treatment of body dysmorphic disorder (review of the evidence and a recommended treatment approach). CNS Spectrums. 2002;7:453–460
  13. Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry. 2002;59:381–388
  14. Hollander E, Allen A, Kwon J, Aronowitz B, Schmeidler J, Wong C, et al.  Clomipramine vs desipramine crossover trial in body dysmorphic disorder (selective efficacy of a serotonin reuptake inhibitor in imagined ugliness). Arch Gen Psychiatry. 1999;56:1033–1039
  15. McDonough M, Kennedy N. Pharmacological management of obsessive-compulsive disorder (a review for clinicians). Harvard Rev Psychiatry. 2002;10:127–137
  16. Griest JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch Gen Psychiatry. 1995;52:53–60
  17. Leonard HL, Swedo SE, Lenane MC, Rettew DC, Cheslow DL, Hamburger SD, et al.  A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry. 1991;48:922–927
  18. Rosen JC, Reiter J, Orosan P. Cognitive behavioral body image therapy for body dysmorphic disorder. J Consult Clin Psychol. 1995;63:263–269
  19. Veale D, Gournay K, Dryden W, Boocock A, Shah F, Willson R, et al.  Body dysmorphic disorder (a cognitive behavioural model and pilot randomized controlled trial). Behav Res Ther. 1996;34:717–729
  20. Foa EB, Kozak MJ. Psychological treatment for obsessive-compulsive disorder. In:  Mavisssakalian MR,  Prien RF editor. Long-Term Treatments of Anxiety Disorders. Washington, DC: American Psychiatric Press; 1996;p. 285–309
  21. Freeston MH, Ladouceur R, Rheaume J, Letarte H, Thibodeau N, Gagnon R, et al.  Cognitive-behavior treatment of obsessive thoughts. J Consult Clin Psychiatry. 1997;65:405–413
  22. DeLeon J, Bott A, Simpson GM. Dysmorphobia (body dysmorphic disorder or delusional disorder, somatic subtype?). Compr Psychiatry. 1989;30:457–472
  23. McKenna PJ. Disorders with overvalued ideas. Br J Psychiatry. 1984;145:579–585
  24. Vitiello B, deLeon J. Dysmorphobia misdiagnosed as obsessive-compulsive disorder. Psychosomatics. 1990;31:220–222
  25. Eisen JL, Phillips KA, Baer L, Beer DA, Atala KD, Rasmussen SA. The Brown Assessment of Beliefs Scale (reliability and validity). Am J Psychiatry. 1998;155:102–108
  26. Garety PA, Hemsley DR. Characteristics of delusional experience. Eur Arch Psychiatry Neurol Sci. 1987;236:294–298
  27. Kendler KS, Glazer WM, Morgenstern H. Dimensions of delusional experience. Am J Psychiatry. 1983;140:466–469
  28. Eisen JL, Rasmussen SA, Phillips KA, Price LH, Davidson J, Lydiard RB, et al.  Insight and treatment outcome in obsessive-compulsive disorder. Compr Psychiatry. 2001;42:494–497
  29. Neziroglu F, McKay D, Yaryura-Tobias JA, Stevens KP, Todaro J. The overvalued ideas scale (development, reliability, and validity in obsessive-compulsive disorder). Behav Res Ther. 1999;37:881–902
  30. Phillips KA, McElroy SL, Keck PE, Pope HG, Hudson JI. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull. 1994;30:179–186
  31. Diagnostic and Statistical Manual of Mental Disorders. Ed. 3. Rev.. Washington. DC: American Psychiatric Association; 1987;
  32. Diagnostic and Statistical Manual of Mental Disorders. Ed. 4. Rev.. Washington, DC: American Psychiatric Association; 1994; Washington
  33. Phillips KA, Dwight MM, McElroy SL. Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry. 1998;59:165–171
  34. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al.  The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Part I: Reliability. Arch Gen Psychiatry. 1989;46:1006–1011
  35. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, et al.  The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Part II: Validity. Arch Gen Psychiatry. 1989;46:1012–1016
  36. Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, et al.  A severity rating scale for body dysmorphic disorder (development, reliability, and validity of a modified version of the Yale-Brown Obsessive-Compulsive Scale). Psychopharmacol Bull. 1997;33:17–22
  37. Rosenthal R, Rosnow RL. Essentials of Behavioral Research (Methods and Data Analysis). Ed. 2. New York, NY: McGraw-Hill; 1991;
  38. Insel TR, Akiskal HS. Obsessive-compulsive disorder with psychotic features (a phenomenological analysis). Am J Psychiatry. 1986;143:1527–1533
  39. Phillips KA, McElroy SL, Dwight MM, Eisen JL, Rasmussen SA. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. J Clin Psychiatry. 2001;62:87–91
  40. Lelliott PT, Noshirvani HF, Basoglu M, Marks IM, Monterio WO. Obsessive-Compulsive Beliefs and Treatment Outcome. Psychol Med. 1988;18:697–702
  41. Lelliott P, Marks I. Management of obsessive-compulsive rituals associated with delusions, hallucinations, and depression (a case report). Behav Psychother. 1987;15:77–87
  42. Foa EB. Failures in treating obsessive-compulsives. Behav Res Ther. 1979;169–176
  43. Foa EB, Abramowitz JS, Franklin ME, Kozak MJ. Feared consequences, fixity of belief, and treatment outcome in patients with obsessive-compulsive disorder. Behav Ther. 1999;30:717–724

 Supported in part by Pfizer Pharmaceuticals (J.L.E.) and by a National Institute of Mental Health grant (R29-MH54841) and an unrestricted grant from Solvay Pharmaceuticals and Pharmacia and Upjohn to K.A.P.

PII: S0010-440X(03)00172-X

doi: 10.1016/j.comppsych.2003.09.010

Comprehensive Psychiatry
Volume 45, Issue 1 , Pages 10-15 , January 2004